title: [Fibrosing pneumopathy caused by labetalol].
abstract: A diffuse interstitial pulmonary fibrosis occurred in a 74-year-old woman treated for ten years with labetalol for systemic hypertension. Bronchoalveolar lavage (BAL) revealed lymphocytic and neutrophilic alveolitis. The lack of another etiologic factor and the spontaneously favorable course after withdrawal of the drug support the hypothesis of a labetalol induced pulmonary fibrosis.
authors.affiliation: Service de Médecine A, CH Remiremont.
authors.forename: A
authors.initials: A
authors.lastname: Kheir
authors.forename: F
authors.initials: F
authors.lastname: Chabot
authors.forename: N
authors.initials: N
authors.lastname: Delorme
authors.forename: J M
authors.initials: JM
authors.lastname: Polu
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D005260:Female; D006801:Humans; D007741:Labetalol / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D000319:Adrenergic beta-Antagonists; D007741:Labetalol
vernacular_title: Pneumopathie fibrosante induite par le labétalol.